bufferin regular strength pain relief

Generic: aspirin

Labeler: genomma lab usa
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name bufferin regular strength pain relief
Generic Name aspirin
Labeler genomma lab usa
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
Genomma Lab USA

Identifiers & Regulatory

Product NDC 50066-610
Product ID 50066-610_4f652a68-82a2-4c22-acc4-2cb28f96b358
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2021-05-17

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50066610
Hyphenated Format 50066-610

Supplemental Identifiers

RxCUI
212033 260847
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bufferin regular strength pain relief (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (50066-610-13) / 130 TABLET, COATED in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

50066-610-13 1 BOTTLE, PLASTIC in 1 CARTON (50066-610-13) / 130 TABLET, COATED in 1 BOTTLE, PLASTIC

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Bufferin Regular Strength Pain Relief ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4f652a68-82a2-4c22-acc4-2cb28f96b358", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["212033", "260847"], "spl_set_id": ["3543b2bf-1062-468a-a5dc-eabb2408af8c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Genomma Lab USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (50066-610-13)  / 130 TABLET, COATED in 1 BOTTLE, PLASTIC", "package_ndc": "50066-610-13", "marketing_start_date": "20210517"}], "brand_name": "Bufferin Regular Strength Pain Relief", "product_id": "50066-610_4f652a68-82a2-4c22-acc4-2cb28f96b358", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "50066-610", "generic_name": "aspirin", "labeler_name": "Genomma Lab USA", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Bufferin Regular Strength Pain Relief", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210517", "listing_expiration_date": "20261231"}